Scan myocardial perfusion abnormal and Weakness
Summary:
Weakness is found among people with Scan myocardial perfusion abnormal, especially for people who are female, 60+ old.
The study analyzes which people have Weakness with Scan myocardial perfusion abnormal. It is created by eHealthMe based on reports of 53 people who have Scan myocardial perfusion abnormal from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Scan myocardial perfusion abnormal?
Scan myocardial perfusion abnormal is found to be associated with 76 drugs and 120 conditions by eHealthMe. Check the latest studies of Scan myocardial perfusion abnormal.
What is Weakness?
Weakness is found to be associated with 3,640 drugs and 6,612 conditions by eHealthMe. Check the latest studies of Weakness.
53 people who have Scan Myocardial Perfusion Abnormal and Weakness are studied.

Gender of people who have Scan Myocardial Perfusion Abnormal and experienced Weakness *:
- female: 59.57 %
- male: 40.43 %
Age of people who have Scan Myocardial Perfusion Abnormal and experienced Weakness *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 6.82 %
- 50-59: 11.36 %
- 60+: 81.82 %
Common co-existing conditions for these people *:
- High Blood Pressure: 2 people, 3.77%
- Heart Palpitations (feelings or sensations that your heart is pounding or racing): 2 people, 3.77%
- Vasodilatation (widening of blood vessels resulting from relaxation of smooth muscle cells within the vessel walls): 1 person, 1.89%
- Quit Smoking: 1 person, 1.89%
- High Blood Cholesterol: 1 person, 1.89%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 1.89%
Common drugs taken by these people *:
- Lexiscan: 30 people, 56.60%
- Adenoscan: 7 people, 13.21%
- Zocor: 4 people, 7.55%
- Advair Diskus 100/50: 4 people, 7.55%
- Hydrochlorothiazide: 4 people, 7.55%
- Regadenoson: 4 people, 7.55%
- Plavix: 4 people, 7.55%
- Thallous Chloride Tl 201: 4 people, 7.55%
- Zyrtec: 3 people, 5.66%
- Levothyroxine Sodium: 3 people, 5.66%
Common symptoms for these people *:
- Nausea (feeling of having an urge to vomit): 13 people, 24.53%
- Dyspnea (difficult or laboured breathing): 11 people, 20.75%
- Dizziness: 10 people, 18.87%
- Tremor (trembling or shaking movements in one or more parts of your body): 10 people, 18.87%
- Chest Pain: 9 people, 16.98%
- Headache (pain in head): 8 people, 15.09%
- Chills (felling of cold): 7 people, 13.21%
- Malaise (a feeling of general discomfort or uneasiness): 6 people, 11.32%
- High Blood Pressure: 6 people, 11.32%
- Hypoaesthesia (reduced sense of touch or sensation): 6 people, 11.32%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Weakness?
- Check whether Weakness is associated with a drug or a conditionRelated studies:
Treatments, associated drugs and conditions:
- Scan myocardial perfusion abnormal (174 reports)
- Weakness (586,876 reports)
All the drugs that are associated with Weakness:
- Weakness (3,640 drugs)
All the conditions that are associated with Weakness:
- Weakness (6,612 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Weakness and Scan myocardial perfusion abnormal, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Oseltamivir Phosphate and Fentanyl - now
- Drug interactions of Tagamet and Propofol - 3 seconds ago
- Drug interactions of Buprenorphine and Gammagard - 4 seconds ago
- Could Tyrosine cause Joint Pain? - 46 seconds ago
- Drug interactions of Acetic Acid and Atrovent - 57 seconds ago
- Could Flagyl cause Weight Loss? - a minute ago
- Drug interactions of Azithromycin and Cefdinir - a minute ago
- Could Montelukast Sodium cause Anaphylaxis? - 2 minutes ago
- Could Meropenem cause Quality Of Life Decreased? - 2 minutes ago
- Drug interactions of Levothyroxine Sodium and Kadcyla - 2 minutes ago